https://www.selleckchem.com/pr....oducts/bay-61-3606.h
Advances in molecular and other imaging will help better characterize RV dysfunction in this population and evaluate the response to therapies.Venous thromboembolism (VTE) is the leading preventable cause of death in hospitalized patients and data consistently show that acutely ill medical patients remain at increased risk for VTE-related morbidity and mortality in the post-hospital discharge period. Prescribing extended thromboprophylaxis for up to 45 days following an acute hospitalization in key patient subgroups that include mor
Like
Comment
Share
